The CHI Health Antimicrobial Stewardship Program (ASP) aims to optimize the treatment of infections and reduce adverse events associated with antibiotic use. This program helps clinicians improve the quality of patient care and improve patient safety through increased infection cure rates, reduced treatment failures, and increased frequency of correct prescribing for therapy and prophylaxis. Through achieving these improved outcomes and appropriate therapies the ASP will have positive financial impacts on the health system.
- Antibiotic resistance is a significant and progressively worsening problem at healthcare facilities around the world. This fact, combined with the lack of new antimicrobial agents in the drug development pipeline, indicates that optimized, judicious antimicrobial management is necessary to preserve the antibiotics currently available.
- Antimicrobial Stewardship Programs have been shown to improve patient outcomes significantly by optimizing dosing for individual patients, reducing toxicity, reducing potential development of resistant infections, and decreasing medication costs, while potentially preserving the therapeutic effectiveness of antimicrobials for populations.
- Effective January 1, 2017, The Joint Commission and Center for Medicare/Medicaid Services requires all hospitals to have a program in place that meets their Antimicrobial Stewardship Standards.
To improve patient safety and outcomes, reduce health care costs, and reduce antibiotic resistance rates throughout the region, CHI Health currently provides Antimicrobial Stewardship Monitoring. Pharmacists and an Infectious Disease provider review real-time alerts and electronic medical record data and make recommendations to improve antimicrobial prescribing and management of infectious diseases. Antimicrobial Stewardship Monitoring is available at all 14 CHI Health hospitals.